Is Adjuvant Therapy Necessary for Patients with Intermediate-Risk Cervical Cancer after Open Radical Hysterectomy?

Introduction: Adjuvant therapy is usually recommended for patients with intermediate-risk cervical cancer (deep stromal invasion [DSI], lymphovascular space invasion [LVSI], and bulky tumor) after radical hysterectomy. However, we previously reported that DSI, LVSI, and bulky squamous cell carcinoma...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology 2020-11, Vol.98 (12), p.853-858
Hauptverfasser:	Yahata, Hideaki, Sonoda, Kenzo, Inoue, Shusaku, Yasutake, Nobuko, Kodama, Keisuke, Yagi, Hiroshi, Yasunaga, Masafumi, Ohgami, Tatsuhiro, Onoyama, Ichiro, Kaneki, Eisuke, Okugawa, Kaoru, Asanoma, Kazuo, Kato, Kiyoko
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Adult Aged Cancer Care and treatment Cervical cancer Chemotherapy, Adjuvant - methods Clinical Study Diagnosis Female Humans Hysterectomy Middle Aged Neoplasm Invasiveness - pathology Neoplasm Invasiveness - prevention & control Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery Patient outcomes Postoperative Period Prognosis Risk Assessment Uterine Cervical Neoplasms - drug therapy Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!